Partner-Assisted Skin Self-Exams Beneficial for Patients with Melanoma

Share this content:
Partner-assisted skin self-examination interventions were efficacious for early detection of individuals with history of melanoma.
Partner-assisted skin self-examination interventions were efficacious for early detection of individuals with history of melanoma.

Twelve months of partner-assisted skin self-examination (SSE) interventions were sustainable and efficacious for early detection targeting individuals with a history of melanoma, according to a recent study published online ahead of print in JAMA Dermatology.

For the study, researchers sought to evaluate three alternative SSE training approaches that included partners versus treatment-as-usual. Previous research has demonstrated that in-person training on SSEs was improved when taught to patients with their partners present.

Researchers randomly assigned 494 patients with stage 0 to IIB melanoma and their partners to an in-person intervention, a take-home booklet intervention, and treatment-as-usual controls. Some patients also received an electronic interactive tablet personal computer intervention.

RELATED: Link Between Citrus Consumption and Melanoma

Results showed no significant differences in SSEs among the three interventions, and results for all three interventions were significantly higher than for controls at 4 and 12 months (all P<0.05).

The findings suggest that partner-assisted SSE interventions are beneficial for patients with a history of melanoma.

Reference

  1. Turrisi R, Hultgren B, Mallett KA, et al. Comparison of efficacy of differing partner-assisted skin examination interventions for melanoma patients. JAMA Dermatol. 2015. [epub ahead of print]. doi: 10.1001/jamadermatol.2015.0690.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters